
Borviz T 2mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Bortezomib (2mg)
Overview Borviz T 2mg Injection
T-Borviz 2mg injection treats multiple myeloma and mantle cell lymphoma by inhibiting or decelerating cancer cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months; discontinue only under medical guidance. Common side effects include fatigue, nausea, vomiting, and anorexia. Increased fluid intake is often recommended. Operate machinery with caution due to potential drowsiness and dizziness. This medication can reduce blood cell counts (red and white), increasing infection risk; regular blood tests monitoring blood cell levels, along with heart, liver, and uric acid levels, are necessary. Prior to use, disclose any liver, kidney, heart disease, or bleeding disorders to your doctor. Report memory loss or cognitive impairment immediately. Inform your healthcare provider of all other medications you are taking, as interactions are possible. Avoid use during pregnancy or breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Uses of Borviz T 2mg Injection
Myeloma and mantle cell lymphoma
Major Benefits of Borviz T 2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Borviz T 2mg Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Borviz T 2mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
How Borviz T 2mg Injection works:
Borviz T 2mg Injection is an anticancer agent that inhibits protein degradation within cells. This process elevates intracellular protein levels in cancerous cells, ultimately causing their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Borviz T 2mg Injection and alcohol may result in significant sedation.
PregnancyCONSULT YOUR DOCTOR
Administering Borviz T 2mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might deem its use necessary if the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingUNSAFE
Administration of Borviz T 2mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harmful effects to the nursing infant.
DrivingUNSAFE
Administering Borviz T 2mg Injection may induce adverse reactions impairing driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual disturbances, potentially affecting safe driving.
KidneyCAUTION
The administration of Borviz T 2mg Injection requires careful consideration in individuals with advanced renal impairment. Dosage modification of Borviz T 2mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Borviz T 2mg Injection. Dosage modification for Borviz T 2mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Borviz T 2mg Injection :
Omit a Borviz T 2mg Injection dose? Seek your physician's advice.
Facts to Know About Borviz T 2mg Injection
Label | Value |
---|---|
Chemical Category | Phenylalanine-based Compounds |
Developing Habits | No. |
Treatment Category | Cancer Medications |